LINEAGE CELL THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.14 USD | +2.70% |
|
-0.87% | +4.59% |
Chart calendar Lineage Cell Therapeutics, Inc.
e4226f0e9877f1496834ef62.F9_63a3oA_tT-6LINwb7c11NeSfNAIiyh7yBmqG2chM.RpuCjdiEcqQRq5v9Y3KUABUbFUSbRL-FzIS02O3uK3pIjLe-x7c6nSOImg~f6e82d3ea2d80fa540e593b704e2253a
Upcoming events on Lineage Cell Therapeutics, Inc.
Past events on Lineage Cell Therapeutics, Inc.
| 2024-03-07 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-07 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-02 | Angiogenesis, Exudation, and Degeneration Meeting |
| 2023-11-09 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-09 04:01 pm | Q3 2023 Earnings Release |
| 2023-10-04 | EURETINA Congress |
| 2023-09-27 09:10 am | Cantor Global Healthcare Conference |
| 2023-09-16 11:10 am | International Spinal Research Trust Network Meeting |
| 2023-09-14 11:50 am | International Spinal Research Trust Network Meeting |
| 2023-09-13 10:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-12 12:50 pm | Baird Global Healthcare Conference |
| 2023-08-10 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-10 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-28 | Spinal Cord Injury Investor Symposium |
| 2023-06-20 01:30 pm | Maxim Group Virtual Healthcare Conference |
| 2023-05-11 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-04-25 02:30 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2023-04-25 10:00 am | American Association of Pharmaceutical Scientists National Biotechnology Conference - Panel |
| 2023-04-20 | Fighting Blindness Foundation and Casey Eye Institute Retinal Cell and Gene Therapy Innovation Summi |
Past dividends on Lineage Cell Therapeutics, Inc.
| 2018-11-28 | 0 USD |
| 2016-01-03 | 0 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,52 2,88 21.88% | 1,83 2,17 -15.84% | 4,34 3,76 15.58% | 14,7 15,3 -4.09% | 8,95 9,70 -7.79% | 17,5 |
|
EBITDA Million USD | Released Forecast Spread | -35,7 -40,8 12.28% | -24,3 -27,5 11.51% | -48,3 -28,4 -69.99% | -21,8 -20,1 -8.58% | -24,0 -25,8 6.82% | -25,5 |
|
EBIT Million USD | Released Forecast Spread | -38,9 -40,4 3.69% | -26,4 -29,4 10.04% | -49,2 -29,7 -65.71% | -22,5 -22,3 -0.89% | -24,7 -24,5 -1% | -21,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,2 -22,9 16% | -21,9 -29,5 25.69% | -43,3 -25,6 -69.14% | -25,8 -26,0 0.7% | -23,3 -24,3 4.27% | -21,5 |
|
Net income Million USD | Released Forecast Spread | -11,7 -15,9 26.31% | -20,6 -30,4 32.12% | -43,0 -24,8 -73.38% | -26,3 -26,3 0.18% | -21,5 -22,9 6.36% | -21,5 |
|
EPS USD | Released Forecast Spread | -0,08 -0,11 25% | -0,14 -0,20 30% | -0,26 -0,14 -80.56% | -0,15 -0,15 2.17% | -0,12 -0,13 9.43% | -0,11 |
| Announcement Date | 12/03/20 | 11/03/21 | 10/03/22 | 09/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,90 1,27 -29.13% | 1,17 0,64 83.65% | 5,24 8,90 -41.17% | 4,55 4,95 -7.96% | 3,00 4,31 -30.49% | 1,92 2,54 -24.61% | 2,39 2,01 18.62% | 3,23 2,19 47.35% | 1,25 2,65 -52.98% | 2,12 2,84 -25.54% | 1,36 | 1,12 | 1,14 | 13,9 | 0,74 |
|
EBITDA Million USD | Released Forecast Spread | -11,9 -14,9 20.2% | -28,0 -7,79 -260.04% | -6,21 5,55 -211.96% | -4,06 -5,45 25.53% | -5,06 -3,97 -27.57% | -6,47 -4,75 -36.13% | -6,47 -6,68 3.13% | -4,85 -6,43 24.45% | -6,53 -5,13 -27.4% | -6,19 -7,40 16.39% | -6,16 | -6,28 | -6,44 | -6,63 | -7,65 |
|
EBIT Million USD | Released Forecast Spread | -28,2 -8,35 -238.38% | -6,40 -9,64 33.63% | -4,23 -3,58 -18.43% | -5,25 -5,31 1.18% | -6,64 -6,43 -3.24% | -6,64 -7,49 11.34% | -5,02 -7,84 35.93% | -6,71 -6,48 -3.49% | -6,36 -5,77 -10.19% | -7,93 | -8,68 | -9,27 | 3,83 | -9,89 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,0 -15,0 0.27% | -28,0 -8,63 -224.44% | -7,09 -7,43 4.47% | -6,78 -4,63 -46.44% | -5,58 -5,74 2.81% | -6,36 -6,50 2.1% | -6,21 -7,02 11.55% | -5,20 -7,40 29.65% | -7,16 -6,34 -12.92% | -4,71 -5,79 18.54% | -7,34 | -7,99 | -8,53 | 2,36 | -9,89 |
|
Net income Million USD | Released Forecast Spread | -14,9 -15,0 0.53% | -29,0 -8,59 -237.39% | -7,09 -7,43 4.55% | -6,76 -4,63 -46.11% | -6,07 -5,73 -5.9% | -6,35 -6,46 1.6% | -4,37 -7,02 37.69% | -5,23 -7,41 29.43% | -7,11 -6,33 -12.32% | -4,78 -7,63 37.45% | -7,04 | -7,99 | -8,52 | 2,05 | -9,87 |
|
EPS USD | Released Forecast Spread | -0,10 -0,10 0% | -0,17 -0,05 -240% | -0,04 -0,05 20% | -0,04 -0,03 -53.85% | -0,04 -0,03 -21.73% | -0,03 -0,04 18.19% | -0,03 -0,04 21.73% | -0,03 -0,04 30.76% | -0,04 -0,04 -11.11% | -0,02 -0,03 33.33% | -0,04 | -0,04 | -0,05 | 0,01 | -0,05 |
| Announcement Date | 06/08/20 | 10/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 09/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for Lineage Cell Therapeutics, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LCTX Stock
- Calendar Lineage Cell Therapeutics, Inc.
